@article{fcead39517cd4602865af6502705224f,
title = "Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia",
keywords = "Cognition, Histamine subtype-3 receptor, MK-0249, Randomized trial, Schizophrenia",
author = "Egan, {Michael F.} and Xin Zhao and Regina Gottwald and Lyn Harper-Mozley and Ying Zhang and Duane Snavely and Christopher Lines and David Michelson",
note = "Funding Information: This study was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. The funding organization was involved in the following: design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. ",
year = "2013",
month = may,
doi = "10.1016/j.schres.2013.02.030",
language = "English",
volume = "146",
pages = "224--230",
journal = "Schizophrenia Research",
issn = "0920-9964",
number = "1-3",
}